388 related articles for article (PubMed ID: 16049031)
21. Activation of the E3 ubiquitin ligase Parkin.
Caulfield TR; Fiesel FC; Springer W
Biochem Soc Trans; 2015 Apr; 43(2):269-74. PubMed ID: 25849928
[TBL] [Abstract][Full Text] [Related]
22. Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.
Fiesel FC; Caulfield TR; Moussaud-Lamodière EL; Ogaki K; Dourado DF; Flores SC; Ross OA; Springer W
Hum Mutat; 2015 Aug; 36(8):774-86. PubMed ID: 25939424
[TBL] [Abstract][Full Text] [Related]
23. Parkin: a multifaceted ubiquitin ligase.
Moore DJ
Biochem Soc Trans; 2006 Nov; 34(Pt 5):749-53. PubMed ID: 17052189
[TBL] [Abstract][Full Text] [Related]
24. The role of parkin in familial and sporadic Parkinson's disease.
Dawson TM; Dawson VL
Mov Disord; 2010; 25 Suppl 1(0 1):S32-9. PubMed ID: 20187240
[TBL] [Abstract][Full Text] [Related]
25. Parkin genetics: one model for Parkinson's disease.
Mata IF; Lockhart PJ; Farrer MJ
Hum Mol Genet; 2004 Apr; 13 Spec No 1():R127-33. PubMed ID: 14976155
[TBL] [Abstract][Full Text] [Related]
26. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
27. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.
Zhang Y; Gao J; Chung KK; Huang H; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13354-9. PubMed ID: 11078524
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death.
Ko HS; von Coelln R; Sriram SR; Kim SW; Chung KK; Pletnikova O; Troncoso J; Johnson B; Saffary R; Goh EL; Song H; Park BJ; Kim MJ; Kim S; Dawson VL; Dawson TM
J Neurosci; 2005 Aug; 25(35):7968-78. PubMed ID: 16135753
[TBL] [Abstract][Full Text] [Related]
29. A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress.
Springer W; Hoppe T; Schmidt E; Baumeister R
Hum Mol Genet; 2005 Nov; 14(22):3407-23. PubMed ID: 16204351
[TBL] [Abstract][Full Text] [Related]
30. Functional modulation of parkin through physical interaction with SUMO-1.
Um JW; Chung KC
J Neurosci Res; 2006 Nov; 84(7):1543-54. PubMed ID: 16955485
[TBL] [Abstract][Full Text] [Related]
31. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
[TBL] [Abstract][Full Text] [Related]
32. Autoregulation of Parkin activity through its ubiquitin-like domain.
Chaugule VK; Burchell L; Barber KR; Sidhu A; Leslie SJ; Shaw GS; Walden H
EMBO J; 2011 Jun; 30(14):2853-67. PubMed ID: 21694720
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration.
Sul JW; Park MY; Shin J; Kim YR; Yoo SE; Kong YY; Kwon KS; Lee YH; Kim E
Hum Mol Genet; 2013 Apr; 22(8):1558-73. PubMed ID: 23307929
[TBL] [Abstract][Full Text] [Related]
34. Pathogenetic mechanisms of parkin in Parkinson's disease.
Hattori N; Mizuno Y
Lancet; 2004 Aug 21-27; 364(9435):722-4. PubMed ID: 15325839
[TBL] [Abstract][Full Text] [Related]
35. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
[TBL] [Abstract][Full Text] [Related]
36. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
[TBL] [Abstract][Full Text] [Related]
37. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin.
Um JW; Han KA; Im E; Oh Y; Lee K; Chung KC
J Neurosci Res; 2012 May; 90(5):1030-42. PubMed ID: 22271254
[TBL] [Abstract][Full Text] [Related]
38. Parkin Is Dispensable for Mitochondrial Function, but Its Ubiquitin Ligase Activity Is Critical for Macroautophagy and Neurotransmitters: Therapeutic Potential beyond Parkinson's Disease.
Moussa CE
Neurodegener Dis; 2015; 15(5):259-70. PubMed ID: 26160424
[TBL] [Abstract][Full Text] [Related]
39. New insights into Parkinson's disease.
Chung KK; Dawson VL; Dawson TM
J Neurol; 2003 Oct; 250 Suppl 3():III15-24. PubMed ID: 14579120
[TBL] [Abstract][Full Text] [Related]
40. SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination.
Trempe JF; Chen CX; Grenier K; Camacho EM; Kozlov G; McPherson PS; Gehring K; Fon EA
Mol Cell; 2009 Dec; 36(6):1034-47. PubMed ID: 20064468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
